Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
Changsong QiBeijing Key Laboratory of Cell & Gene Therapy for Solid Tumour, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Early Drug Development Centre, Peking University Cancer Hospital & Institute, Beijing, China. Electronic address: [email protected]Chang LiuBeijing Key Laboratory of Cell & Gene Therapy for Solid Tumour, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Early Drug Development Centre, Peking University Cancer Hospital & Institute, Beijing, ChinaZhi PengBeijing Key Laboratory of Cell & Gene Therapy for Solid Tumour, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, ChinaYanqiao ZhangHarbin Medical University Cancer Hospital, Harbin, ChinaJia WeiDepartment of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, ChinaWensheng QiuThe Affiliated Hospital of Qingdao University, Qingdao, ChinaXiaotian ZhangBeijing Key Laboratory of Cell & Gene Therapy for Solid Tumour, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, ChinaHongming PanSir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaZuoxing NiuCancer Hospital of Shandong First Medical University, Jinan, ChinaMeng QiuWest China Hospital, Sichuan University, Colorectal Cancer Center, Chengdu, ChinaYanru QinThe First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaWeijia FangZhejiang Provincial Key Laboratory for Drug Evaluation and Clinical Research, Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaFeng YeDepartment of Medical Oncology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, ChinaNing LiHenan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, ChinaTianshu LiuDepartment of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, ChinaAnwen LiuThe Second Affiliated Hospital of Nanchang University, Nanchang, ChinaXizhi ZhangBeijing Key Laboratory of Cell & Gene Therapy for Solid Tumour, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, ChinaChanglu HuAnhui Provincial Cancer Hospital, Hefei, ChinaJun ZhangDepartment of Oncology, Shanghai Key Laboratory of Gastric Neoplasms, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaJiuwei CuiThe First Hospital of Jilin University, Changchun, ChinaXiaoyan LinFujian Medical University Union Hospital, Fuzhou, ChinaShubin WangPeking University Shenzhen Hospital, Shenzhen, ChinaJian ZhangDepartment of Oncology, Shanghai Key Laboratory of Gastric Neoplasms, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaTong-Yu LinDepartment of Medical Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, ChinaXiujuan QuThe First Hospital of China Medical University, Shenyang, ChinaXianglin YuanTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaJifang GongBeijing Key Laboratory of Cell & Gene Therapy for Solid Tumour, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, ChinaJian LiBeijing Key Laboratory of Cell & Gene Therapy for Solid Tumour, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, ChinaWanwan GaoLi GaiYumeng WangDaijing YuanZonghai LiLin ShenBeijing Key Laboratory of Cell & Gene Therapy for Solid Tumour, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China. Electronic address: [email protected]
2025en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0